Stay updated on EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page history.
    Difference
    0.0%
    Check dated 2026-03-19T06:17:13.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 in the study record history.
    Difference
    0.0%
    Check dated 2026-03-12T02:17:37.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the funding-status notice and Revision: v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-11T14:26:51.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    A government funding/operating status notice was added and the page revision updated from v3.4.0 to v3.4.1, removing the prior v3.4.0 reference. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T10:31:01.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    UI text updates on the history page (glossary display option and color-coded change indicators) and versioning changes, updating the No FEAR Act label capitalization and the revision tag from v3.3.4 to v3.4.0.
    Difference
    0.4%
    Check dated 2026-01-28T06:31:42.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    The revision label at the bottom of the page updates from v3.3.3 to v3.3.4. This appears to be a routine platform update and does not change the study information or results.
    Difference
    0.0%
    Check dated 2026-01-14T03:37:45.000Z thumbnail image

Stay in the know with updates to EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page.